10 Sept 2026

Case #005

1

Presenting complaint

Patient history

A 45-year-old woman presents with sudden-onset shortness of breath and right-sided pleuritic chest pain that began two hours ago. She returned from a 14-hour international flight three days ago and takes a combined oral contraceptive pill.

2Clue sealed:Physical examination
3Clue sealed:Laboratory results
4Clue sealed:ECG
5Clue sealed:Imaging
6Clue sealed:Imaging

Pick a diagnosis from the suggestion list, then tap Submit to lock it in.

Reveal the answer (counts as a forfeit)

Diagnosis

Pulmonary embolism (PE)

Key clinical clues

  • Risk factors: recent long-haul flight plus oral contraceptive use
  • Sudden pleuritic chest pain, tachycardia, and hypoxia
  • S1Q3T3 pattern on ECG
  • CT pulmonary angiography showing bilateral filling defects
  • DVT identified as the embolic source on lower extremity ultrasound

First-line treatment

Therapeutic anticoagulation

Two risk factors compound here rather than merely coexist: fourteen hours of immobility three days ago, and an oestrogen-containing pill that raises clotting factor levels for as long as it is taken. Sudden pleuritic pain with hypoxia and a clear chest is the useful combination, because it is the absence of findings on auscultation that makes pneumonia and pneumothorax poor fits for this degree of hypoxia. The blood gas quietly confirms the mechanism. A pH of 7.49 with a PaCO2 of 29 is a respiratory alkalosis from blowing off carbon dioxide, meaning she is hyperventilating and still only managing 91 per cent, which is dead space rather than a ventilation problem. The ECG shows the same thing from another angle: sinus tachycardia, with a prominent S wave in lead I, a Q wave in lead III and an inverted T wave there, the S1Q3T3 pattern of an acutely strained right ventricle. It is worth recognising but not worth waiting for, specific enough to be a useful hint and far too insensitive to exclude anything, and plain sinus tachycardia is the commoner finding. She is haemodynamically stable, which is the finding that determines treatment. Anticoagulation alone is therefore enough, and a direct oral anticoagulant such as apixaban or rivaroxaban, both direct factor Xa inhibitors, is preferred for most patients; low molecular weight heparin is used instead in pregnancy and active cancer. It is started on suspicion rather than on the scan when suspicion is high, since the wait is the dangerous part. Systemic thrombolysis is held back for high-risk PE with haemodynamic instability, because the bleeding risk only justifies itself against an immediate threat to life.